Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratumoral Clostridium novyi-NT spores in advanced soft tissue sarcoma
CTR20231747Phase 2Terminated
- Sponsor
- Shandong Xinchuang Biotechnology
- Start
- Jun 2023
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of XC-01 in soft tissue sarcoma (STS), sponsored by Shandong Xinchuang Biotechnology. Started Jun 2023; status: terminated.
02
Drugs
XC-01
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on CTR20231747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231747.